Sharon Curran

Sharon Curran is a board member at MorphoSys and was previously with Noden Pharma. Sharon has also worked with Circassia and AbbVie. Sharon has over 25 years of experience in the pharmaceutical industry, with a focus on global marketing and capability development. Sharon has led strategy for the Speciality Franchise Portfolio covering Neuroscience Neurology, Neonatology & Niche Therapeutic Areas. Sharon has full $USD Multi-Billion P&L responsibility, plus accountability for long-term growth plans (USD$ Multi-Billion targets by 2020). Some of their key achievements include rejuvenating a neurology drug and leading in-market team for strategic market + region (Board Member & SVP Operations).

Sharon Curran is a Chartered Director (CDir) from the Institute of Directors (IoD). Sharon also has an Executive MSc in Management/Business Administration from Trinity College Dublin, as well as a BSc in Biotechnology from Dublin City University. Lastly, they are an Associate of the Institute of Medical Laboratory Science from the Technological University Dublin.